Enhanced Elimination of Poison
Drug Elimination: Non-Renal Routes
The Blood-brain Barrier
Drug Excretion: Miscellaneous Routes
Drug Elimination by Renal Route: Tubular Reabsorption
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 29, 2025

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
Published on: May 7, 2018
1Laboratory of Neurovascular Inflammation and Neurodegeneration, Department of Biomedical Engineering, Center for Injury Bio Mechanics, Materials and Medicine, New Jersey Institute of Technology Newark, NJ 07102, United States.
The brain uses specialized pathways to clear waste metabolites, which are harmful byproducts of normal function. Since the brain lacks a lymphatic system, it relies on cerebrospinal fluid (CSF) to clear small solutes. However, larger waste products like Aβ protein require an alternative route. This review discusses perivascular clearance (PVC), a newly identified pathway that allows waste to move from the interstitial space into perivascular regions, either directly or via CSF. The authors suggest that improving this pathway could help reduce the buildup of harmful waste and potentially treat neurological diseases.
Area of Science:
Background:
The brain requires constant energy to regulate essential functions like circulation and respiration. This energy is supplied through active transport of nutrients across the blood-brain barrier (BBB). While this process is normal, the movement of harmful substances like xenobiotics or inflammatory agents across these interfaces can damage brain cells. This damage leads to the accumulation of waste metabolites. The brain lacks a lymphatic system, so cerebrospinal fluid (CSF) is used to clear small solutes. However, larger waste products like Aβ protein are not efficiently removed through this pathway. This gap in understanding motivates a closer look at how waste is cleared from the brain. Prior research has identified the BBB, blood-spinal cord barrier, and choroid plexus as key interfaces. Yet, the mechanisms for removing large waste metabolites remain unclear. This uncertainty drives the need to explore alternative pathways like perivascular clearance.
Purpose Of The Study:
This review aims to clarify how waste metabolites are cleared from the brain. The focus is on the interfaces that regulate transport into and out of the central nervous system (CNS). The BBB, blood-spinal cord barrier, and choroid plexus are central to this discussion. The review also considers the harmful effects of xenobiotics and inflammatory agents crossing these barriers. The accumulation of waste metabolites is linked to neurological complications. Since the CNS lacks a lymphatic system, alternative pathways like perivascular clearance (PVC) are of interest. The goal is to identify mechanisms that allow waste to move from the interstitial space into PVC or via IS-CSF-PVC. The study also aims to explore how these pathways exchange waste metabolites into the circulation for removal.
Main Methods:
The authors conducted a literature review focusing on the CNS interfaces that regulate waste clearance. They examined the BBB, blood-spinal cord barrier, and choroid plexus as primary sites of transport. The review also included recent findings on perivascular clearance (PVC) and its role in removing waste metabolites. The authors analyzed the movement of waste from the interstitial space (IS) into PVC or via IS-CSF-PVC pathways. They evaluated how these pathways facilitate the exchange of waste metabolites into the circulation. The study did not involve new experiments but synthesized existing evidence. The authors compared the efficiency of CSF-based clearance for small solutes versus larger waste products like Aβ protein. The review approach included a detailed analysis of how xenobiotics and inflammatory agents contribute to waste accumulation.
Main Results:
The review highlights that the BBB and related interfaces are essential for transporting nutrients into the brain. However, these same interfaces allow harmful substances to enter, leading to waste metabolite production. The CNS lacks a lymphatic system, so CSF is used to clear small solutes but not large waste like Aβ protein. The review identifies perivascular clearance (PVC) as a key pathway for removing larger waste metabolites. Waste can move directly from the interstitial space (IS) into PVC or via IS-CSF-PVC. The exchange of waste from PVC into the circulation is also discussed. The study found that PVC is more effective for clearing large waste metabolites than CSF alone. The review suggests that improving PVC function could enhance waste clearance and reduce neurological complications.
Conclusions:
The authors propose that perivascular clearance (PVC) is a critical mechanism for removing large waste metabolites from the brain. Since the CNS lacks a lymphatic system, alternative pathways like PVC are necessary for maintaining brain homeostasis. The review suggests that the movement of waste from the interstitial space into PVC or via IS-CSF-PVC is a viable clearance route. The exchange of waste from PVC into the circulation is also important for complete removal. The authors highlight that xenobiotics and inflammatory agents contribute to waste accumulation and neurological complications. They propose that improving PVC function could be a therapeutic strategy for neurological diseases. The review concludes that understanding these clearance mechanisms is essential for developing new treatments. The findings suggest that enhancing waste clearance could ameliorate neurological conditions.
PVC is a pathway that allows waste metabolites to move from the interstitial space into perivascular regions, either directly or via cerebrospinal fluid.
The brain uses perivascular clearance (PVC) to remove large waste metabolites, as the lymphatic system is absent and cerebrospinal fluid alone is insufficient.
The BBB regulates nutrient transport but also allows harmful substances to enter, leading to waste metabolite accumulation that requires clearance mechanisms like PVC.
CSF clears small solutes but not large waste metabolites like Aβ protein, which rely on perivascular clearance pathways for removal.
The IS is the site where waste metabolites accumulate before being transported into perivascular clearance pathways for removal.
The authors propose that enhancing PVC function could reduce waste accumulation and ameliorate neurological complications like those seen in Alzheimer’s disease.